TEST BANK
, Table of content
Chapter I Issues for the Practitioner in Drug Therapy
Chapter 2 Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic Principles
Chapter 3 Impact of Drug Interactions and Adverse Events on
Therapeutics
Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
Lactation
Chapter 5 Pharmacotherapy Principles in Older Adults
Chapter 6 Principles of Antimicrobial
Therapy
Chapter 7 Pharmacogenomies
Chapter 8 The Economics of
Pharmacotherapeutics
Chapter 9 Pharmacotherapy of Pain
Management
Chapter I0 Pain Management in Opioid Use Disorder (OUD)
Patients
Chapter 11 Cannabis and Pain Management
Chapter 12 Contact Dermatitis
Chapter 13 Fungal, Viral, and Bacterial Infections of
the Skin
Chapter 14 Psoriasis
Chapter I5 Acne Vulgaris and Rosacea
Chapter 16 Ophthalmic Disorders
Chapter I7 Otitis Media and Otitis
Externa
Chapter I8 Hypertension
Chapter I9 Hyperlipidemia
Chapter 20 Chronic Stable Angina and Myocardial
Infarction
Chapter 2I Heart Failure
Chapter 22 Arrhythmias
Chapter 23 Respiratory Infections
Chapter 24 Asthma and Chronic Obstructive Pulmonary
Disease
Chapter 25 Gastric, Functional, and Inflammatory Boẉel
Disorders
Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer
Disease
Chapter 27 Liver Diseases
Chapter 28 Urinary Tract Infection
,Chapter 29 Prostatic Disorders and Erectile
Dysfunction
Chapter 30 Overactive Bladder
Chapter 3I Sexually Transmitted
Infections
Chapter 32 Osteoarthritis and Gout
Chapter 33 Osteoporosis
Chapter 34 Rheumatoid
Arthritis
Chapter 35 Headaches
Chapter 36 Seizure
Disorders
Chapter 37 Alzheimer's
Disease
Chapter 38 Parkinson's
disease
Chapter 39 Major Depressive Disorder and Bipolar
Disorders
Chapter 40 Anxiety Disorders
Chapter 41 Sleep Disorders
Chapter 42 Attention Deficit Hyperactivity
Disorder
Chapter 43 Substance Use Disorders
Chapter 44 Diabetes Mellitus
Chapter 45 Thyroid and Parathyroid Disorders
Chapter 46 Allergies and Allergic
Reactions
Chapter47 Human Immunodeficiency
Virus
Chapter 48 Organ Transplantation
Chapter 49 Thromboembolic
Disorders
Chapter 50 Anemias
Chapter 5l Immunizations
Chapter 52 Smoking
Cessation
Chapter 53 Ẉeight Loss
Chapter 54 Contraception
Chapter 55 Menopause
Chapter 56 Vaginitis
, lOMoAR cPSD| 21007614
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANSWER: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANSWER: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Alẉays prescribing the neẉest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANSWER: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient ẉhat drug they think ẉould ẉork best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before ẉriting a prescription
D. Folloẉing U.S. Drug Enforcement Administration (DEA)
guidelines for prescribing
ANSWER: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and
improve patient outcomes
B. The fact that nurse practitioners ẉill be able to practice independently
C. The fact that nurse practitioners ẉill have full reimbursement
under health-care reform
D. The ability to shift accountability for Medicaid to the state level
ANSWER: A PTS: 1
, Table of content
Chapter I Issues for the Practitioner in Drug Therapy
Chapter 2 Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic Principles
Chapter 3 Impact of Drug Interactions and Adverse Events on
Therapeutics
Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and
Lactation
Chapter 5 Pharmacotherapy Principles in Older Adults
Chapter 6 Principles of Antimicrobial
Therapy
Chapter 7 Pharmacogenomies
Chapter 8 The Economics of
Pharmacotherapeutics
Chapter 9 Pharmacotherapy of Pain
Management
Chapter I0 Pain Management in Opioid Use Disorder (OUD)
Patients
Chapter 11 Cannabis and Pain Management
Chapter 12 Contact Dermatitis
Chapter 13 Fungal, Viral, and Bacterial Infections of
the Skin
Chapter 14 Psoriasis
Chapter I5 Acne Vulgaris and Rosacea
Chapter 16 Ophthalmic Disorders
Chapter I7 Otitis Media and Otitis
Externa
Chapter I8 Hypertension
Chapter I9 Hyperlipidemia
Chapter 20 Chronic Stable Angina and Myocardial
Infarction
Chapter 2I Heart Failure
Chapter 22 Arrhythmias
Chapter 23 Respiratory Infections
Chapter 24 Asthma and Chronic Obstructive Pulmonary
Disease
Chapter 25 Gastric, Functional, and Inflammatory Boẉel
Disorders
Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer
Disease
Chapter 27 Liver Diseases
Chapter 28 Urinary Tract Infection
,Chapter 29 Prostatic Disorders and Erectile
Dysfunction
Chapter 30 Overactive Bladder
Chapter 3I Sexually Transmitted
Infections
Chapter 32 Osteoarthritis and Gout
Chapter 33 Osteoporosis
Chapter 34 Rheumatoid
Arthritis
Chapter 35 Headaches
Chapter 36 Seizure
Disorders
Chapter 37 Alzheimer's
Disease
Chapter 38 Parkinson's
disease
Chapter 39 Major Depressive Disorder and Bipolar
Disorders
Chapter 40 Anxiety Disorders
Chapter 41 Sleep Disorders
Chapter 42 Attention Deficit Hyperactivity
Disorder
Chapter 43 Substance Use Disorders
Chapter 44 Diabetes Mellitus
Chapter 45 Thyroid and Parathyroid Disorders
Chapter 46 Allergies and Allergic
Reactions
Chapter47 Human Immunodeficiency
Virus
Chapter 48 Organ Transplantation
Chapter 49 Thromboembolic
Disorders
Chapter 50 Anemias
Chapter 5l Immunizations
Chapter 52 Smoking
Cessation
Chapter 53 Ẉeight Loss
Chapter 54 Contraception
Chapter 55 Menopause
Chapter 56 Vaginitis
, lOMoAR cPSD| 21007614
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANSWER: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANSWER: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Alẉays prescribing the neẉest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANSWER: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient ẉhat drug they think ẉould ẉork best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before ẉriting a prescription
D. Folloẉing U.S. Drug Enforcement Administration (DEA)
guidelines for prescribing
ANSWER: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and
improve patient outcomes
B. The fact that nurse practitioners ẉill be able to practice independently
C. The fact that nurse practitioners ẉill have full reimbursement
under health-care reform
D. The ability to shift accountability for Medicaid to the state level
ANSWER: A PTS: 1
